• 3337 Citations
  • 27 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Mingyi Chen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Neoplasms Medicine & Life Sciences
Oxidized LDL Receptors Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Natural Killer Cells Medicine & Life Sciences
Class E Scavenger Receptors Medicine & Life Sciences
Graft vs Host Disease Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Hematopoietic Stem Cell Transplantation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2019

12 Citations (Scopus)

Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade

Pai, C. C. S., Huang, J. T., Lu, X., Simons, D. M., Park, C., Chang, A., Tamaki, W., Liu, E., Roybal, K. T., Seagal, J., Chen, M., Hagihara, K., Wei, X. X., DuPage, M., Kwek, S. S., Oh, D. Y., Daud, A., Tsai, K. K., Wu, C., Zhang, L. & 7 others, Fasso, M., Sachidanandam, R., Jayaprakash, A., Lin, I., Casbon, A. J., Kinsbury, G. A. & Fong, L., Feb 19 2019, In : Immunity. 50, 2, p. 477-492.e8

Research output: Contribution to journalArticle

Clonal Deletion
Tumor Burden
3 Citations (Scopus)

Disruption of the RBM38-eIF4E complex with a synthetic peptide PEP8 increases p53 expression

Lucchesi, C. A., Zhang, J., Ma, B., Chen, M. & Chen, X., Feb 15 2019, In : Cancer Research. 79, 4, p. 807-818 12 p.

Research output: Contribution to journalArticle

Eukaryotic Initiation Factor-4E
Eukaryotic Initiation Factors
RNA-Binding Proteins
Dendritic Cells
Bone Marrow
Immune Tolerance
Antigen-Presenting Cells
Immune System

Evolving myelodysplastic syndrome in an HIV patient with history of anal cancer and chemotherapy

Shi, M., Hu, X. & Chen, M., Dec 1 2019, In : Journal of Hematopathology. 12, 4, p. 213-214 2 p.

Research output: Contribution to journalArticle

Anus Neoplasms
Myelodysplastic Syndromes
Drug Therapy
Chromosome Aberrations
1 Citation (Scopus)

Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity

Liu, Z., Han, C., Dong, C., Shen, A., Hsu, E., Ren, Z., Lu, C., Liu, L., Zhang, A., Timmerman, C., Pu, Y., Wang, Y., Chen, M., Qiao, J. & Fu, Y. X., Aug 9 2019, In : Science Immunology. 4, 38

Research output: Contribution to journalArticle

Adaptive Immunity
Epidermal Growth Factor Receptor
Innate Immunity
Protein-Tyrosine Kinases